mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.08 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |